Andere Kunden interessierten sich auch für
![Colorectal Cancer, An Issue of Hematology/Oncology Clinics]( "Colorectal Cancer, An Issue of Hematology/Oncology Clinics")
Colorectal Cancer, An Issue of Hematology/Oncology Clinics68,99 €![Breast Cancer, An Issue of Hematology/Oncology Clinics of North America]( "Breast Cancer, An Issue of Hematology/Oncology Clinics of North America")
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America59,99 €![Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America]( "Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America")
Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America59,99 €![Gastric Cancer, an Issue of Gastrointestinal Endoscopy Clinics]( "Gastric Cancer, an Issue of Gastrointestinal Endoscopy Clinics")
Gastric Cancer, an Issue of Gastrointestinal Endoscopy Clinics75,99 €![MR Imaging of Chronic Liver Diseases and Liver Cancer, an Issue of Magnetic Resonance Imaging Clinics of North America]( "MR Imaging of Chronic Liver Diseases and Liver Cancer, an Issue of Magnetic Resonance Imaging Clinics of North America")
MR Imaging of Chronic Liver Diseases and Liver Cancer, an Issue of Magnetic Resonance Imaging Clinics of North America75,99 €![Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America")
Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America72,99 €![Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America")
Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America57,99 €
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!